Vaccinex Inc (OTCPK:VCNX) Stock News, Headlines & Updates
Vaccinex Inc Stock News from GuruFocus
- 1
May 27, 2025
Vaccinex (VCNX) Showcases Pepinemab's Role in Enhancing Cancer Immunotherapy | VCNX Stock News
GuruFocus News • 8:16am
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting | VCNX Stock News
GuruFocus News • 8:00am
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
Marketwired • 8:00am
Apr 21, 2025
Vaccinex (VCNX) Presents New Findings on Pepinemab for Cancer Treatment | VCNX Stock News
GuruFocus News • 8:20am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news